HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program Nasdaq:HTGM

Press/Media

Period23 Jan 2019

Media coverage

1

Media coverage

  • TitleHTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program Nasdaq:HTGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date23/01/19
    PersonsJoseph Sparano
View all 1
View less